Artiva develops natural killer cell therapies for autoimmune diseases and cancers, based in San Diego, California. It last closed at $3.78 on Nov 20, down 1.31% on the day. The next earnings report for ARTV is expected around Tue, Mar 9, 2027, after the close. Over its last 8 reports the stock moved an average of 11.0% the session after earnings. Over the last 12 months ARTV insiders bought $109.1M of stock on the open market and sold $3.5M, according to SEC Form 4 filings.
AI Auto Pilots
Is ARTV in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ARTV.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ARTVStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ARTV · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 10% below its 20 day and 58% below its 50 day average. It is 112% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 22), oversold. The nearest support is the Pivot S1 at $3.72, and the nearest resistance the Pivot at $3.83.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityLow, 6.9%/day
Key levels
$14.5352 week high+284.4%
$8.30100 day average+119.6%
$8.00200 day average+111.6%
$5.9750 day average+57.9%
$4.28Swing high (Nov 4)+13.2%
$4.1820 day average+10.6%
$3.88Pivot R1+2.6%
$3.83Pivot+1.3%
$3.78Last close
$3.72Pivot S1−1.6%
$2.9652 week low−21.7%
Indicators
RSI (14)
22.21
Oversold below 30
Oversold
MACD
-0.67
Above its signal line
Bullish
Stochastic
8.2
Near the bottom of its range
Oversold
ADX (14)
60.5
Strong downtrend
Williams %R
-94.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-109.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−8.9%
Change over 10 sessions
Bearish
ATR (14)
$0.26
Typical daily range, 6.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityNormal, 33.6%/day
Key levels
$14.5352 week high+284.4%
$8.30100 day average+119.6%
$8.00200 day average+111.6%
$5.9750 day average+57.9%
$4.28Swing high (Nov 4)+13.2%
$4.1820 day average+10.6%
$3.88Pivot R1+2.6%
$3.83Pivot+1.3%
$3.78Last close
$3.72Pivot S1−1.6%
$2.9652 week low−21.7%
Indicators
RSI (14)
29.61
Oversold below 30
Oversold
MACD
-1.11
Below its signal line
Bearish
Stochastic
1.1
Near the bottom of its range
Oversold
ADX (14)
31.8
Trending down
Williams %R
-99.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-123.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−63.0%
Change over 10 sessions
Bearish
ATR (14)
$1.27
Typical daily range, 33.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for ARTV
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ARTV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ARTVHow many large options trades hit ARTV, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ARTV in the last 90 days.
From SEC Form 4 filings by ARTV's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ARTV is in one of them and how their past ARTV trades turned out.
Artiva is a biotechnology company based in San Diego, California, that is developing cell therapies made from natural killer cells, a type of immune cell. Its lead product candidate, AlloNK, is made from donor cells, frozen and shipped ready for use, and is designed to work alongside antibody medicines to deplete B cells. The company is testing AlloNK in clinical trials for autoimmune diseases such as rheumatoid arthritis and Sjögren's disease, and it also has programs aimed at cancers. The intended patients are people with these conditions, and the product is not yet approved for sale.